A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia
NCT03533244
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
64
Enrollment
INDUSTRY
Sponsor class
Conditions
Pterygium
Interventions
DRUG:
0.1% AG-86893 Eye Drops
DRUG:
0.3% AG-86893 Eye Drops
DRUG:
Vehicle Eye Drops
Sponsor
Allgenesis Biotherapeutics Inc.